74 related articles for article (PubMed ID: 19895889)
1. IFN-gamma and Fas/FasL pathways cooperate to induce medial cell loss and neointimal lesion formation in allograft vasculopathy.
Hart-Matyas M; Nejat S; Jordan JL; Hirsch GM; Lee TD
Transpl Immunol; 2010 Feb; 22(3-4):157-64. PubMed ID: 19895889
[TBL] [Abstract][Full Text] [Related]
2. CD8(+) T cells mediate aortic allograft vasculopathy under conditions of calcineurin immunosuppression: role of IFN-gamma and CTL mediators.
Nejat S; Zaki A; Hirsch GM; Lee TD
Transpl Immunol; 2008 May; 19(2):103-11. PubMed ID: 18503885
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
4. CD8+ T cells mediate aortic allograft vasculopathy by direct killing and an interferon-gamma-dependent indirect pathway.
Skaro AI; Liwski RS; Zhou J; Vessie EL; Lee TD; Hirsch GM
Cardiovasc Res; 2005 Jan; 65(1):283-91. PubMed ID: 15621057
[TBL] [Abstract][Full Text] [Related]
5. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation.
Matter CM; Chadjichristos CE; Meier P; von Lukowicz T; Lohmann C; Schuler PK; Zhang D; Odermatt B; Hofmann E; Brunner T; Kwak BR; Lüscher TF
Circulation; 2006 Apr; 113(15):1879-87. PubMed ID: 16606788
[TBL] [Abstract][Full Text] [Related]
6. Impairment of recipient cytolytic activity attenuates allograft vasculopathy.
Skaro AI; Liwski RS; O'Neill J; Vessie EL; Zhou J; Hirsch GM; Lee TD
Transpl Immunol; 2005 Mar; 14(1):27-35. PubMed ID: 15814279
[TBL] [Abstract][Full Text] [Related]
7. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
8. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
Winter H; Hu HM; Urba WJ; Fox BA
J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388
[TBL] [Abstract][Full Text] [Related]
9. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection.
Guillermo LV; Silva EM; Ribeiro-Gomes FL; De Meis J; Pereira WF; Yagita H; DosReis GA; Lopes MF
J Leukoc Biol; 2007 Apr; 81(4):942-51. PubMed ID: 17261545
[TBL] [Abstract][Full Text] [Related]
10. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
[TBL] [Abstract][Full Text] [Related]
11. Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells.
Williams NS; Engelhard VH
J Immunol; 1997 Sep; 159(5):2091-9. PubMed ID: 9278294
[TBL] [Abstract][Full Text] [Related]
12. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
13. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes.
Sobek V; Balkow S; Körner H; Simon MM
Eur J Immunol; 2002 Sep; 32(9):2490-9. PubMed ID: 12207333
[TBL] [Abstract][Full Text] [Related]
14. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Miura Y; Thoburn CJ; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
[TBL] [Abstract][Full Text] [Related]
15. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine-insensitive partial signaling and multiple roles of Ca2+ in Fas ligand-induced lysis.
Rogers AM; Thilenius AR; Russell JH
J Immunol; 1997 Oct; 159(7):3140-7. PubMed ID: 9317111
[TBL] [Abstract][Full Text] [Related]
18. Aortic allograft vasculopathy is mediated by CD8(+) T cells in Cyclosporin A immunosuppressed mice.
Vessie EL; Hirsch GM; Lee TD
Transpl Immunol; 2005 Oct; 15(1):35-44. PubMed ID: 16223671
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma regulates Fas ligand expression in human CD4+ T lymphocytes and controls their anti-mycobacterial cytotoxic functions.
Boselli D; Losana G; Bernabei P; Bosisio D; Drysdale P; Kiessling R; Gaston JS; Lammas D; Casanova JL; Kumararatne DS; Novelli F
Eur J Immunol; 2007 Aug; 37(8):2196-204. PubMed ID: 17595676
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]